Sam Vorkpor
Family Medicine · Manchester, KYNPI 1700076874
Payments from drug & device makers
Across 65 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$211
- Novo Nordisk$121
- AstraZeneca$105
- Lilly USA, LLC$90
- Merck$68
- Medtronic$58
- plus $459 from 16 others
What the payments were for
- Food & beverage$1,113100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $211 |
| Novo Nordisk | 7 | $121 |
| AstraZeneca | 7 | $105 |
| Lilly USA, LLC | 5 | $90 |
| Merck | 4 | $68 |
| Medtronic | 3 | $58 |
| Sunovion Pharmaceuticals Inc. | 3 | $54 |
| Novartis | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| GSK | 2 | $38 |
| Johnson & Johnson | 2 | $35 |
| Astellas Pharma US Inc | 2 | $30 |
| Amarin Pharma, Inc. | 2 | $28 |
| Boehringer Ingelheim | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Shield Therapeutics Inc | 1 | $25 |
| Amgen | 1 | $23 |
| Bayer | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Pfizer | 1 | $13 |
| Insulet Corporation | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,113 in reported general payments places this provider in the 55th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 481 | $80,443 |
| OzempicSemaglutide | 84 | $79,851 |
| JanuviaSitagliptin Phosphate | 135 | $77,643 |
| EliquisApixaban | 84 | $56,498 |
| LinzessLinaclotide | 79 | $43,433 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 26 | $23,365 |
| XareltoRivaroxaban | 30 | $20,076 |
| MounjaroTirzepatide | 18 | $18,914 |
| JardianceEmpagliflozin | 29 | $17,298 |
| SynjardyEmpagliflozin/Metformin Hcl | 28 | $16,787 |
| Spiriva HandihalerTiotropium Bromide | 32 | $16,077 |
| Victoza 2-PakLiraglutide | 21 | $15,113 |
| Victoza 3-PakLiraglutide | 14 | $13,603 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,287 | $13,205 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $11,887 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $121 | $79,85184 claims |
| MerckJanuvia | $68 | $77,643135 claims |
| PfizerEliquis, Premarin | $13 | $58,58597 claims |
| Boehringer IngelheimCombivent Respimat, Jardiance, Synjardy | $27 | $57,45083 claims |
| AbbVieLinzess | $211 | $43,43379 claims |
| Lilly USA, LLCMounjaro, Trulicity | $90 | $29,47929 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $38 | $22,28643 claims |
| Johnson & JohnsonXarelto | $35 | $20,07630 claims |
| AstraZenecaFarxiga | $105 | $10,98420 claims |
| Astellas Pharma US IncMyrbetriq | $30 | $8,06918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Manchester
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
- Jeffrey GreenParis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.